Beta Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR)
Beta Drugs Ltd · Financial Result · 22 Oct 2026, 4:43 pm
Beta Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR) ■ Revenue: 1,37,48,87,594 (+33.0% YoY | +9.5% QoQ) ■ EBITDA: 30,28,04,262 (+42.1% YoY | +10.6% QoQ) ■ EBITDA Margin (%): 22.0 (+141 bps YoY | +23 bps QoQ) ■ PAT: 18,55,07,075 (+51.8% YoY | +17.4% QoQ) ■ EPS (INR): 16.6 (+37.1% YoY | +12.2% QoQ)
Original exchange filing (PDF)
More announcements from Beta Drugs Ltd
- BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 19-Nov-2026 to consider Other business. · 16 Nov 2026
- To consider other business matters · 16 Nov 2026
- Monitoring Agency Report as on 30th September, 2026 · 12 Nov 2026
- Beta Drugs Limited has informed the Exchange about Transcript · 28 Oct 2026
- Beta Drugs Limited has informed the Exchange about Link of Recording · 22 Oct 2026
- Beta Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 · 22 Oct 2026
- Beta Drugs Limited has informed the Exchange about Presentation · 22 Oct 2026
- Beta Drugs Limited has informed the Exchange about Schedule of meet · 22 Oct 2026
